Serum iron in catatonia and neuroleptic malignant syndrome

Biological Psychiatry

Volumn 44, Issue 6, 1998, Pages 499-507

  Lee, Joseph W Y ^a  

^a GRAYLANDS HOSPITAL   (Australia)

Author keywords

Benzodiazepines; Catatonia; Electroconvulsive therapy; Lithium; Neuroleptic malignant syndrome; Serum iron

Indexed keywords

BENZODIAZEPINE DERIVATIVE; IRON; LITHIUM;

ADULT; AGED; ARTICLE; CATATONIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; INTENSIVE CARE; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEUROLEPTIC MALIGNANT SYNDROME; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CATATONIA; FEMALE; HUMANS; IRON; MALE; MIDDLE AGED; NEUROLEPTIC MALIGNANT SYNDROME; PROSPECTIVE STUDIES;

EID: 0032530137     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00109-7     Document Type: Article

References (43)

1. Abrams R., Taylor M.A. Catatonia A prospective clinical study . Arch Gen Psychiatry. 33:1976;579-581.
2. Addonizio G., Susan V.L. ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome. J Clin Psychiatry. 48:1987;102-105.
3. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. 1994;American Psychiatric Press, Washington, DC.
4. Bigelow L.B., Weinberger D.R., Wyatt R.J. Synergism of combined lithium-neuroleptic therapy A double blind, placebo-controlled case study . Am J Psychiatry. 138:1981;81-83.
5. Bush G., Fink M., Petrides G., Dowling F., Francis A. Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand. 93:1996;129-136.
6. Bush G., Fink M., Petrides G., Dowling F., Francis A. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand. 38:1996;137-143.
7. Caroff S.N. The neuroleptic malignant syndrome. J Clin Psychiatry. 41:1980;79-83.
8. Carroll B.T., Goforth H.W. Serum iron in catatonia. Biol Psychiatry. 38:1995;776-777.
9. Chandler J.D. Psychogenic catatonia with elevated creatine kinase and autonomic hyperactivity. Can J Psychiatry. 36:1991;530-532.
10. Climo L.H. Treatment-resistant catatonic stupor and combined lithium-neuroleptic therapy A case report . J Clin Psychopharmacol. 5:1985;166-170.
11. Cohen W.J., Cohen N.H. Lithium carbonate, haloperidol, and irreversible brain damage. JAMA. 230:1974;1283-1287.
12. Fink M. Recognizing NMS as a type of catatonia. J Neuropsychiatry Neuropsychol Behav Neurol. 8:1995;75-76.
13. Fink M. Neuroleptic malignant syndrome and catatonia One entity or two? Biol Psychiatry. 39:1996;1-4.
14. Fleischhacker W.W., Unterweger B., Kane J.M., Hinterhuber H. The neuroleptic malignant syndrome and its differentiation from lethal catatonia. Acta Psychiatr Scand. 81:1990;3-5.
15. Greenfeld D., Conrad C., Kincare P., Bowers M.B. Jr. Treatment of catatonia with low-dose lorazepam. Am J Psychiatry. 144:1987;1224-1225.
16. Kellam A.M.P. The neuroleptic malignant syndrome, so called. Br J Psychiatry. 150:1987;752-759.
17. Lee J.W.Y., Robertson S. Clozapine withdrawal catatonia and neuroleptic malignant syndrome A case report . Ann Clin Psychiatry. 9:1997;165-169.
18. Levenson J.L. Neuroleptic malignant syndrome. Am J Psychiatry. 142:1985;1137-1145.
19. Lohr J.B., Wisenewski A.A. Movement Disorders - A Neuropsychiatric Approach. 1987;Guilford Press, New York.
20. Mann S.C., Caroff S.N., Bleier H.R., Welz W.K.R., Kling M.A., Hayashida M. Lethal catatonia. Am J Psychiatry. 143:1986;1374-1381.
21. Menza M.A., Harris D. Benzodiazepines and catatonia An overview . Biol Psychiatry. 26:1989;842-846.
22. Morrison J.R. Catatonia Retarded and excited types . Arch Gen Psychiatry. 28:1973;39-41.
23. Pataki J., Zervas I.M., Jandorf L. Catatonia in a university inpatient service (1985-1990). Convuls Ther. 8:1992;163-173.
24. Pertursson H. Lithium treatment of a patient with periodic catatonia. Acta Psychiatr Scand. 54:1976;248-253.
25. Philbrick K.I., Rummans T.A. Malignant catatonia. J Neuropsychiatry Clin Neurosci. 6:1994;1-13.
26. Pope H.G., Keck P.E., McElroy S.L. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry. 143:1986;1227-1233.
27. Rohland B.M., Carroll B.T., Jacoby R.G. ECT in the treatment of the catatonic syndrome. J Affect Disord. 29:1993;255-261.
28. Rosebush P.I., Mazurek M.F. Serum iron and neuroleptic malignant syndrome. Lancet. 338:1991;149-151.
29. Rosebush P., Steward T. A prospective analysis of 24 episodes of NMS. Am J Psychiatry. 146:1989;717-725.
30. Rosebush P.I., Hildebrand A.M., Furlong B.G., Mazurek M.F. Catatonic syndrome in a general hospital psychiatric population Frequency, clinical presentation, and response to lorazepam . J Clin Psychiatry. 51:1990;357-362.
31. Salem S.A., Pillai A., Beresford T.P. Lorazepam for psychogenic catatonia. Am J Psychiatry. 144:1987;1082-1083.
32. Shalev A., Munitz H. The neuroleptic malignant syndrome Agent and host interaction . Acta Psychiatr Scand. 73:1986;337-347.
33. Singerman B., Raheja R. Malignant catatonia - A continuing reality. Ann Clin Psychiatry. 6:1994;259-266.
34. Spring G., Frankel M. New data on lithium and haloperidol incompatibility. Am J Psychiatry. 138:1981;818-821.
35. Stauder K.H. Die todliche Katatonie. Arch Psychiatr Nervenkr. 102:1934;614-634.
36. Taylor M.A. Catatonia A review of a behavioral neurologic syndrome . Neuropsychiatry Neuropsychol Behav Neurol. 3:1990;48-72.
37. Ungvari G.S., Leung C.M., Wong M.K., Lau J. Benzodiazepines in the treatment of catatonic syndrome. Acta Psychiatr Scand. 89:1994;285-288.
38. Vinogradov S., Reiss A.L. Use of lorazepam in treatment-resistant catatonia. J Clin Psychopharmacol. 6:1986;323-325.
39. Weller M., Kornhuber J. Serum iron levels in neuroleptic malignant syndrome. Biol Psychiatry. 34:1993;123-124.
40. White A.C. Catatonia and the neuroleptic malignant syndrome - A single entity? Br J Psychiatry. 161:1992;558-560.
41. White T., Brown K. Low serum iron levels and neuroleptic malignant syndrome. Am J Psychiatry. 148:1990;148.
42. White A.C., Robins A.H. Catatonia Harbinger of the neuroleptic malignant syndrome . Br J Psychiatry. 158:1991;419-421.
43. White A.C., Robins A.H. Catatonia and neuroleptic malignant syndrome. Br J Psychiatry. 158:1991;858-859.